...
  • 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>Management research >Industry-university interaction strategies of large Brazilian pharmaceutical companies Estrategias de interaccion industria-universidad de las grandes empresas farmaceuticas brasilenas Estrategias de interacao industria-universidade das grandes empresas farmaceuticas brasileiras
【24h】

Industry-university interaction strategies of large Brazilian pharmaceutical companies Estrategias de interaccion industria-universidad de las grandes empresas farmaceuticas brasilenas Estrategias de interacao industria-universidade das grandes empresas farmaceuticas brasileiras

机译：大型巴西制药公司的行业-大学互动策略Interacao大型巴西制药公司的行业-大学互动策略

获取原文
获取原文并翻译 | 示例
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

Purpose - The purpose of this paper is to analyze the strategies and organizational forms used by large Brazilian pharmaceutical companies (LBPCs) in interaction with universities for the development of innovation. Design/methodology/approach - In the pharmaceutical industry, a science-based sector, the source of new knowledge is often outside the company environment. Thus, the search for innovation depends on the company's strategic decisions of cooperation. This research uses the case study method, with secondary data from the 2008, 2011 and 2014 Innovation Survey (Pintec) about the innovative efforts of LBPCs, as well as primary data from semi-structured interviews with six of them. Findings - The most recent data on innovation in Brazil show changes in the innovative efforts of LBPCs, involving the raise in the interaction with universities. The results of the field research also show that the LBPCs have differentiated innovative structures and are effectively using strategies for partnerships with universities, through the creation of radical innovation departments, the establishment of internal scientific committees and the internationalization of research and development. Originality/value - These findings contribute to the literature on the industry-university interactions in Brazil and in developing countries. However, this analysis cannot be generalized for the Brazilian pharmaceutical industry as it uses the case study method. Moreover, it is too early to determine if the identified strategies were successful. Nonetheless, it is worth mentioning that the strategies of the six interviewed companies differ greatly from the patterns of the Brazilian pharmaceutical industry and the manufacturing industry.
机译：目的-本文的目的是分析大型巴西制药公司（LBPC）与大学合作用于创新发展的策略和组织形式。设计/方法/方法-在制药业（基于科学的领域）中，新知识的来源通常位于公司环境之外。因此，寻求创新取决于公司的战略合作决策。本研究使用案例研究方法，并获得了来自2008、2011和2014年创新调查（Pintec）的有关LBPC创新工作的辅助数据，以及来自其中六个机构的半结构化访谈的主要数据。调查结果-巴西最新的创新数据表明，低收入国家的创新努力发生了变化，其中包括与大学之间互动的增加。实地研究的结果还表明，低收入国家委员会通过建立激进的创新部门，建立内部科学委员会以及研究与开发的国际化，已经区分了创新结构，并有效地利用了与大学建立伙伴关系的策略。原创性/价值-这些发现为有关巴西和发展中国家的产业-大学互动提供了文献资料。但是，这种分析不能用于巴西制药业，因为它使用了案例研究方法。此外，确定所确定的策略是否成功还为时过早。但是，值得一提的是，接受采访的六家公司的战略与巴西制药业和制造业的模式大不相同。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号